Jaw Abnormalities
Conditions
Keywords
three-dimensional virtual treatment planning, orthognathic surgery
Brief summary
Orthognathic surgery or corrective jaw surgery is indicated for conditions of the jaw and face that are related to structure or growth malfunctioning, orthodontic problems, or co-morbidities associated with skeletal disfigurement. Imaging is crucial in the assessment and treatment planning of orthognathic surgery patients. Until recently, two-dimensional (2D) imaging, through cephalometry, was standard practice. However, it showed several limitations. The introduction of the cone-beam computed tomography (CBCT) enabling three-dimensional (3D) imaging has caused a paradigm shift. Though widespread implementation in routine practice is not yet present. Our department is one of the pioneers in the world of 3D virtual treatment planning for orthognathic surgery. The triple CBCT scan procedure has been developed in-house and implemented already in 2009. The investigators aim to develop a prospective database registering 3D treatment planning data of all consecutive patients eligible for orthognathic surgery, performed by Prof. Swennen. Patient demographics, detailed virtual 3D treatment planning parameters and orthognathic surgery data are being collected during consecutive visits within the framework of routine practice. Development of a database registering 3D virtual treatment planning data of orthognathic surgery, will provide more information about potential patient, virtual planning and surgical factors influencing postoperative accuracy of jaw correction, long-term stability of the jawbone, long-term condylar resorption, or soft tissue response. In general, it could provide answers on research questions that have been examined in prior studies on 2D-imaging, but can now be re-examined in case of 3D-imaging. Moreover, registration of those results could function as a measurement of quality of care, or could be used for sample size calculation for future large multicenter prospective trials.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients of all ages * Both female and male patients * Patients should present themselves at the Department of Oral and Maxillofacial Surgery of the General Hospital Saint-John Bruges for orthognathic surgical treatment * Patients receive standardized cone-beam computed tomography (CBCT) image acquisition (i-CAT, Imaging sciences international, inc, Hatfield, USA) according to the triple CBCT scan protocol * Patients' orthognathic surgery should be prepared by a standardized setup of an augmented 3D virtual patient model in centric relation, with detailed occlusal and intercuspidation data using the triple voxel-based rigid registration protocol (Maxilim v2.2.2., Nobel Biocare c/o Medicim nv, Mechelen, Belgium) * Patients' surgery should be prepared preoperatively through 3D virtual planning steps performed with the same software, by the same surgeon (GS) * Patients should be operated by the same surgeon (GS)
Exclusion criteria
* All patients that do not fit in the abovementioned description * Patients with posttraumatic deformity * Patients with congenital deformity * Patients with preprosthetic indication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of hard tissue, soft tissue and teeth transfer after 3D planning, as measured with CBCT | within 12 months postoperative |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy of bone transfer, as measured through superimposition of 3D planning CBCT and postoperative CBCT | 4 weeks postoperative |
| Long-term stability, through clinical evaluation and superimposition of 3D planning CBCT and postoperative CBCT | 6 months postoperative |
| Prevalence of patients with an indication for orthognathic surgery | 6 years |
| number of patients with temporomandibular joint complications | until 12 months postoperative |
| number of patients with condylar resorption | until 12 months postoperative |
Other
| Measure | Time frame |
|---|---|
| sample size calculation for future large prospective trials, based on pilot data | 6 years |
Countries
Belgium